Bank of New York Mellon’s Agile Therapeutics, Inc AGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-20
| Closed | -$9K | – | 4742 |
|
|
2022
Q1 | $9K | Hold |
20
| – | – | ﹤0.01% | 4644 |
|
|
2021
Q4 | $20K | Hold |
20
| – | – | ﹤0.01% | 4584 |
|
|
2021
Q3 | $39K | Sell |
20
-6
| -23% | -$11.7K | ﹤0.01% | 4463 |
|
|
2021
Q2 | $69K | Sell |
26
-72
| -73% | -$191K | ﹤0.01% | 4273 |
|
|
2021
Q1 | $408K | Sell |
98
-1
| -1% | -$4.16K | ﹤0.01% | 3794 |
|
|
2020
Q4 | $568K | Sell |
99
-5
| -5% | -$28.7K | ﹤0.01% | 3557 |
|
|
2020
Q3 | $634K | Sell |
104
-1
| -1% | -$6.1K | ﹤0.01% | 3370 |
|
|
2020
Q2 | $584K | Buy |
105
+77
| +275% | +$428K | ﹤0.01% | 3398 |
|
|
2020
Q1 | $103K | Buy |
28
+1
| +4% | +$3.68K | ﹤0.01% | 3849 |
|
|
2019
Q4 | $135K | Buy |
27
+12
| +80% | +$60K | ﹤0.01% | 3978 |
|
|
2019
Q3 | $36K | Hold |
15
| – | – | ﹤0.01% | 4137 |
|
|
2019
Q2 | $45K | Hold |
15
| – | – | ﹤0.01% | 4123 |
|
|
2019
Q1 | $47K | Sell |
15
-1
| -6% | -$3.13K | ﹤0.01% | 4092 |
|
|
2018
Q4 | $18K | Hold |
16
| – | – | ﹤0.01% | 4163 |
|
|
2018
Q3 | $11K | Hold |
16
| – | – | ﹤0.01% | 4216 |
|
|
2018
Q2 | $15K | Sell |
16
-1
| -6% | -$938 | ﹤0.01% | 4180 |
|
|
2018
Q1 | $89K | Sell |
17
-2
| -11% | -$10.5K | ﹤0.01% | 4070 |
|
|
2017
Q4 | $105K | Buy |
19
+10
| +111% | +$55.3K | ﹤0.01% | 4072 |
|
|
2017
Q3 | $81K | Sell |
9
-1
| -10% | -$9K | ﹤0.01% | 4033 |
|
|
2017
Q2 | $71K | Sell |
10
-18
| -64% | -$128K | ﹤0.01% | 4084 |
|
|
2017
Q1 | $182K | Sell |
28
-4
| -13% | -$26K | ﹤0.01% | 3899 |
|
|
2016
Q4 | $361K | Buy |
32
+1
| +3% | +$11.3K | ﹤0.01% | 3716 |
|
|
2016
Q3 | $434K | Sell |
31
-1
| -3% | -$14K | ﹤0.01% | 3606 |
|
|
2016
Q2 | $484K | Buy |
32
+3
| +10% | +$45.4K | ﹤0.01% | 3553 |
|
|
2016
Q1 | $355K | Buy |
29
+8
| +38% | +$97.9K | ﹤0.01% | 3571 |
|
|
2015
Q4 | $408K | Hold |
21
| – | – | ﹤0.01% | 3600 |
|
|
2015
Q3 | $282K | Buy |
21
+5
| +31% | +$67.1K | ﹤0.01% | 3757 |
|
|
2015
Q2 | $272K | Buy |
+16
| New | +$272K | ﹤0.01% | 3806 |
|